NF2 Biosolutions
Donations deductibleRevenue
$226k
year to 31 December 2024
Expenses
$317k
year to 31 December 2024
Total assets
$622k
$102k liabilities
Net assets
$520k
assets less liabilities
Directors and trustees
7
6.3 years on average
Staff
0
employees, year to 31 December 2024
Left since last filing
0
no seats appear to have opened
Officers and senior staff
6
named in Part VII
NF2 Biosolutions' network
7 people4 organisationsi7 people and 4 organisations on this map.The large node is the subject of this page. Solid lines are what the register itself records (7). Violet dotted lines (4) are likely: the same full name sits on the current board of another organisation in the same register and region. Form 990 filings give names without a person identifier; SEC insider filings carry a CIK. It may be a different person.The board
7 listediTime on the board is observed from the annual filings: the IRS files no appointment date, so the bar counts years from the first filing the person appears on - a lower bound, not a filed start date. Names are exactly as filed. The IRS publishes no person identifier, so this edition does not yet link a person across organisations in the tables. The network map shows same-name matches as likely links only, never as confirmed.Time served and departures are observed across annual filings. Observed time served is a lower bound - a member may have joined before the first year on record. The organisation reported 13 voting members of its governing body on its latest Form 990 Part VI; we list 7 in Part VII (Part VII does not always name every voting member).| Name | Role as filed | Since | On the board |
|---|---|---|---|
| Amy Williams | Director | 2020 | 6 yrs |
| Brian Clay | Director | 2020 | 6 yrs |
| Chantelle Nobis | Director | 2020 | 6 yrs |
| Chris Serle | Director | 2020 | 6 yrs |
| Penny Henwood | Director | 2020 | 6 yrs |
| Terri Rausch | Director | 2021 | 5 yrs |
| Vito Grasso | Director | 2020 | 6 yrs |
Under 5 years5 to 6 years6 years or more
Officers and senior leadership
6 listediNamed in Part VII as officers, key employees or highest-compensated staff - not board members, shown for completeness.| Name | Title as filed | On the filings |
|---|---|---|
| Deian Owen | Treasurer | since 2020 |
| Gilles Atlan | Vice- President | since 2020 |
| Jill Velez | Company secretary | since 2020 |
| John Manth | Director | since 2020 |
| Mary Sell | Director | since 2022 |
| Nicole Henwood | President | since 2020 |
Pay and hours
year to 31 December 2024iFrom Part VII of the Form 990: compensation reported for each officer, director, trustee, key employee and highest-paid staff member, and the average hours a week they report. Most board members are unpaid; a blank means nothing was reported. Pay from related organisations is shown separately.| Name | Title as filed | Hours a week | Pay from the organisation | Related organisations | Other |
|---|---|---|---|---|---|
| Nicole Henwood | President | 20 | $13k | ||
| Gilles Atlan | Vice President | 20 | $3k | ||
| Vito Grasso | Director | 1 | $0 | ||
| Chris Serle | Director | 1 | $0 | ||
| Amy Williams | Director | 5 | $0 | ||
| Deian Owen | Treasurer | 5 | $0 | ||
| Mary Sell | Director | 5 | $0 | ||
| Jill Velez | Secretary | 5 | $0 | ||
| Claudia Schmidt | Director | 5 | $0 |
About
- Legal name
- NF2 Biosolutions
- EIN
- 830940046
- Address
- 9 Lian Dr, West Chester, PA, 19382-6891
- State
- Pennsylvania
- Mission
- Seeking a cure or preventative treatment for nf2 by vigorously supporting and advancing existing and next generation biomedical technologies such as gene transfer therapy and immunontherapy (as filed on the Form 990)
- Activity (NTEE)
- G20 Voluntary health associations and medical disciplines
- IRS classification
- 501(c)03 (tax-exempt under section 501(c)(3) where shown)
- Classified purpose
- Voluntary Health Associations & Medical Disciplines
- Size band
- 5 (IRS master file code)
- Formed
- 2018
- IRS ruling date
- 1 July 2018
- Status
- Code 01 (unconditional exemption)
- Form 990 filings on record
- 4, latest 2023
- IRS Publication 78
- PC (contributions deductible)
Most connected
Longest observed on the filings
≥6years on the filingsAmy Williams
≥6years on the filingsBrian Clay
≥6years on the filingsChantelle Nobis
≥6years on the filingsChris Serle
Latest return
year to 31 December 2024iFigures from the newest Form 990 or 990-EZ in the IRS e-file releases of 2025 and 2026, for the year ending 31 December 2024. US dollars, as filed.- Total assets
- $622k
- Total liabilities
- $102k
- Net assets or fund balances
- $520k
- Contributions and grants received
- $185k
- Program service revenue
- $0
- Grants and similar paid out
- $163k
- Employees
- 0
Grants paid
4 listediFrom Schedule I of the Form 990: grants and assistance to organisations in the United States, largest first (up to 25). Schedule I is filed only by organisations that gave more than $5,000 to any one recipient.| Recipient | Purpose | Amount |
|---|---|---|
| Research Institute at Nationwide Ch | $60k | |
| Mass Gen Development Office | Development of bacteriotherapy for nf2 | $60k |
| Yale University | Tumor imaging model | $36k |
| Merlin Therapeutics | $6k |
State registration
1 entityiBusiness-entity registers published by US states. These records are matched to this organisation by name and state, not by EIN, and are labelled as likely matches. Street addresses are not shown.Nf2 Biosolutions likely matchiMatched by exact name and state (and ZIP where shown). State registers do not publish EINs, so this is not a confirmed match. Source: Pennsylvania Department of State, business entities (data.pa.gov xvd7-5r2c). Licence: public domain. Data last fetched 18 October 2026.
- State
- Pennsylvania
- Entity type
- Domestic Nonprofit Corporation
- Status
- Active
- Formed
- 1 June 2018
- Registered agent
- Not stated
Officers (3)
- Gilles Atlan Vice President
- Nicole Henwood President
- Nicole Henwood Governor
City and state of officers are not held in this extract.